Gelteq Limited Quick Ratio (GELS) starting from the fourth quarter 2025 to fourth quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Gelteq Limited  (GELS)

Gelteq Limited's Quick Ratio

GELS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Gelteq Limited's Cash & cash equivalent grew by 1283.6 % in the Q4 2025 sequentially, faster than Current Liabilities, this led to improvement in Gelteq Limited's Quick Ratio to 0.06, above Gelteq Limited average Quick Ratio.

Within Major Pharmaceutical Preparations industry 525 other companies have achieved higher Quick Ratio than Gelteq Limited in fourth quarter 2025. While Quick Ratio total ranking has improved so far during the Q4 2025 to 4824, from total ranking in the fourth quarter 2024 at 5254.

Explain Quick Ratio?
How much Cash & cash equivalents GELS´s has?
What are GELS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GELS Quick Ratio (Jun 30 2025)
Q4		 (Jun 30 2024)
Q3		 0
Q2		 0
Q1		 0
Y / Y Current Liabilities Change -4.24 % 5.97 % - - -
Y / Y Cash & cash equivalent Change 823.81 % -93.84 % - - -
Quick Ratio MRQ 0.06 0.01 0.01 0.01 0.01
GELS's Total Ranking # 4824 # 5254 # # #
Seq. Current Liabilities Change 43.41 % 0 % -21.33 % -15.12 % 58.71 %
Seq. Cash & cash equivalent Change 1283.6 % 0 % -33.23 % 0 % -90.78 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 526
Healthcare Sector # 1052
Overall Market # 4824


Quick Ratio Statistics
High Average Low
0.11 0.03 0.01
(Jun 30 2023)   (Jun 30 2024)




Financial Statements
Gelteq Limited's Current Liabilities $ 4 Millions Visit GELS's Balance sheet
Gelteq Limited's Cash & cash equivalent $ 0 Millions Visit GELS's Balance sheet
Source of GELS's Sales Visit GELS's Sales by Geography


Cumulative Gelteq Limited's Quick Ratio

GELS's Quick Ratio for the trailling 12 Months

GELS Quick Ratio

 (Jun 30 2025)
12 Months		 (Jun 30 2024)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months
Y / Y Current Liabilities TTM Growth 92.73 % 405.35 % - - -
Y / Y Cash & cash equivalent TTM Growth -2.31 % -69.25 % - - -
Quick Ratio TTM 0.02 0.01 0.03 0.03 0.05
Total Ranking TTM # 3965 # 0 # # #
Seq. Current Liabilities TTM Growth -1.33 % 1.19 % 26.94 % 52.07 % 158.71 %
Seq. Cash & cash equivalent TTM Growth 246.99 % -75.32 % 5.2 % 8.44 % 9.22 %

Quick ratio ranking by company, industry and sector >> Back to GELS Financial Strength Comparisons >> Go to Compare GELS Quick Ratio to its Competitors

On the trailing twelve months basis GELS Cash & cash equivalent more than doubled by 823.81 % in Q4 2025 year on year, while Current Liabilities soared to $4 millions, this led to increase in in Gelteq Limited's Quick Ratio to 0.02, Quick Ratio remained below GELS average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 497 other companies have achieved higher Quick Ratio than Gelteq Limited. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2024 from 0 to 3965.

Explain Quick Ratio?
How much Cash & cash equivalents GELS´s has?
What are GELS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 498
Healthcare Sector # 1032
Within the Market # 3965


trailing twelve months Quick Ratio Statistics
High Average Low
0.06 0.06 0.06
(Jun 30 2025)  




Companies with similar Quick Ratio in the quarter ending Jun 30 2025, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2025 MRQ Cash & cash equivalentJun 30 2025 MRQ Current Liabilities
Abbvie Inc   0.16 $ 6,467.000  Millions$ 39,767.000  Millions
Cv Sciences Inc   0.16 $ 0.886  Millions$ 5.466  Millions
Heron Therapeutics Inc   0.16 $ 40.633  Millions$ 258.601  Millions
Kyntra Bio Inc   0.15 $ 23.367  Millions$ 155.895  Millions
Reshape Lifesciences Inc  0.15 $ 0.383  Millions$ 2.599  Millions
Redhill Biopharma Ltd   0.14 $ 2.866  Millions$ 20.056  Millions
Gsk Plc  0.12 $ 4,754.859  Millions$ 41,130.339  Millions
Casi Pharmaceuticals inc   0.11 $ 5.632  Millions$ 49.670  Millions
Eli Lilly And Company  0.09 $ 3,546.000  Millions$ 39,019.900  Millions
Hcw Biologics Inc   0.09 $ 2.439  Millions$ 26.846  Millions
Viatris Inc   0.08 $ 566.400  Millions$ 7,133.400  Millions
Jaguar Health Inc   0.08 $ 2.207  Millions$ 29.218  Millions
Amneal Pharmaceuticals Inc   0.07 $ 81.186  Millions$ 1,107.134  Millions
Nrx Pharmaceuticals Inc   0.07 $ 2.910  Millions$ 40.453  Millions
Abvc Biopharma Inc   0.07 $ 0.453  Millions$ 6.533  Millions
Sonnet Biotherapeutics Holdings Inc   0.06 $ 0.321  Millions$ 5.102  Millions
Gelteq Limited  0.06 $ 0.227  Millions$ 3.702  Millions
Provectus Biopharmaceuticals Inc   0.06 $ 0.386  Millions$ 6.493  Millions
Summit Therapeutics Inc   0.06 $ 4.265  Millions$ 72.019  Millions
The Greater Cannabis Company Inc   0.06 $ 0.027  Millions$ 0.451  Millions
NIKA PHARMACEUTICALS, INC  0.05 $ 0.016  Millions$ 0.284  Millions
Northwest Biotherapeutics Inc  0.05 $ 4.316  Millions$ 83.921  Millions
Nasus Pharma Ltd   0.05 $ 0.203  Millions$ 4.432  Millions
REGENEREX PHARMA, INC.  0.04 $ 0.173  Millions$ 3.877  Millions
Semnur Pharmaceuticals Inc   0.04 $ 0.250  Millions$ 6.569  Millions
Polomar Health Services, Inc.  0.04 $ 0.014  Millions$ 0.372  Millions
IMPACT BIOMEDICAL INC.  0.03 $ 0.624  Millions$ 23.172  Millions
Lexaria Bioscience Corp   0.02 $ 0.034  Millions$ 1.458  Millions
Scorpius Holdings inc   0.02 $ 0.521  Millions$ 23.277  Millions
Blue Water Vaccines Inc  0.02 $ 0.284  Millions$ 12.692  Millions

Date modified: 2026-09-10T02:29:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.